Supernus Pharmaceuticals focuses on developing and commercializing products for the treatment of central nervous system diseases.
Business Model:
Revenue: $659M
Employees: 501-1,000
Address: 9715 Key West Avenue
City: Rockville
State: MD
Zip: 20850
Country: US
Supernus Pharmaceuticals focuses on developing and commercializing products for the treatment of central nervous system diseases.
Contact Phone:
+13018382500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/1/2012
Ticker Symbol:
SUPN
IPO Price:
$5/share
Amount Raised:
$50M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2013 | Post-IPO Debt | $90M | 1/2006 | Series A | 2 | $27.5M |
New Enterprise Associates OrbiMed New Enterprise Associates New Enterprise Associates OrbiMed New Enterprise Associates |
1/2012 | Private Equity Round | $42M | 3/2018 | Post-IPO Debt | $350M | 1/2011 | Debt Financing | $30M | 7/2009 | Unattributed | $110M | 6/2012 | Unattributed | $42M | 4/2012 | IPO | $50M |
|
---|
Announced Date | Name | Price |
---|---|---|
10/2021 | Adamas Pharmaceuticals | |
9/2018 | Biscayne NeuroTherapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|